Immatics (NASDAQ:IMTX – Get Rating) and Sangamo Therapeutics (NASDAQ:SGMO – Get Rating) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, profitability, risk, valuation, institutional ownership, analyst recommendations and earnings. Profitability This table compares Immatics and Sangamo Therapeutics’ net margins, […]